Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Senores Pharmaceuticals Ltd.
₹780
₹775.00
₹802.00
₹440.30
₹876.50
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 28.76 | 35.33 | 19.82 | 11.86 | 9.59 |
| Operating Expense | 29.69 | 33.81 | 20.97 | 14.60 | 12.01 |
| Operating Profit | -0.93 | 1.52 | -1.15 | -2.74 | -2.42 |
| Depreciation | 3.58 | 3.65 | 1.88 | 1.27 | 0.75 |
| Interest | 1.75 | 1.58 | 1.76 | 2.35 | 2.70 |
| Tax | 0.87 | 1.22 | 0.90 | 0.88 | 0.25 |
| Net Profit | 2.65 | 6.43 | 2.70 | 2.01 | 1.07 |
₹780.00
↗ Bullish Moving Average
8
↘ Bearish Moving Average
8
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoter | 45.8 | 45.8 | 45.8 | 45.8 | 45.8 |
| FII | 4.2 | 4.2 | 3.7 | 4.3 | 3.4 |
| DII | 11.8 | 9.6 | 9.5 | 8.6 | 9.3 |
| Public | 38.2 | 40.4 | 41 | 41.3 | 41.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 78.57 K | 1.54 L | 51.09% |
| Week | 1.12 L | 2.43 L | 46.08% |
| 1 Month | 75.92 K | 1.56 L | 48.82% |
| 6 Month | 1.27 L | 2.81 L | 45.05% |
Benjamin Graham Value Screen
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Companies with reducing Debt
Increasing Revenue every Quarter for the past 4 Quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹5.54 | ₹99.90 | ₹101.40 | ₹114.80 | ₹16.50 | ₹214 |
| % Change | 4.92% | 7.48% | 1.59% | 3.07% | 0.00% | 5.94% |
| Revenue TTM (₹ Cr) | ₹83.60 | - | ₹282.74 | - | - | - |
| Net Profit TTM (₹ Cr) | ₹-34.95 | - | ₹15.30 | - | - | - |
| PE TTM | -1.30 | 12.30 | 25.30 | - | 5.70 | 35.00 |
| 1 Year Return | 428 | -27.38 | -20.79 | 22.4 | -61.63 | 110.42 |
| ROCE | -5.63 | - | - | - | - | - |
Alpa Laboratories Ltd.
₹ 50.26
+8.18%
Sun Pharma Advanced Research Company Ltd.
₹ 119.53
+4.04%
SMS Pharmaceuticals Ltd.
₹ 391.90
+4.55%
Nectar Lifesciences Ltd.
₹ 9.76
+4.95%
Mangalam Drugs and Organics Ltd.
₹ 28.50
+4.97%
Indoco Remedies Ltd.
₹ 180.38
+9.99%
Ind-Swift Laboratories Ltd.
₹ 139.90
+6.44%
Lincoln Pharmaceuticals Ltd.
₹ 592.00
+4.79%
Panacea Biotec Ltd.
₹ 327.10
+10.49%
Medicamen Biotech Ltd.
₹ 244.45
+9.47%
Themis Medicare Ltd.
₹ 72.92
+10.37%
Venus Remedies Ltd.
₹ 861.05
+5.00%
Medicamen Organics Ltd.
₹ 22.15
+4.98%
Amrutanjan Health Care Ltd.
₹ 504.00
+2.10%
Bal Pharma Ltd.
₹ 65.00
+7.58%
Hikal Ltd.
₹ 160.55
+9.16%
NGL Fine - Chem Ltd.
₹ 2130.40
+3.56%
Hester Biosciences Ltd.
₹ 1358.60
+7.90%
Natural Capsules Ltd.
₹ 154.49
+7.02%
Krebs Biochemicals & Industries Ltd.
₹ 43.00
+8.18%
Kilitch Drugs(I) Ltd.
₹ 135.59
+8.95%
Syncom Formulation (India) Ltd.
₹ 11.08
+7.57%
Aarey Drugs & Pharmaceuticals Ltd.
₹ 53.28
+4.99%
By signing up I certify terms, conditions & privacy policy